Advertisement

Topics

Outcome Sciences, Inc. Company Profile

16:18 EST 21st November 2017 | BioPortfolio

Outcome is the leading provider of patient registries, studies, quality improvement programs, and integrated technologies for evaluating real-world outcomes. Outcome provides services and technologies focused on evaluating the safety, effectiveness, and quality of healthcare products and services. The company has designed, developed, and managed more than 175 patient registries, including many of the largest and most well-recognized programs for disease outcomes and patient safety.


News Articles [257 Associated News Articles listed on BioPortfolio]

Nandini Ramani Joins Outcome Health as Chief Engineering Officer

NEW YORK, Aug. 28, 2017 /PRNewswire/ -- Outcome Health, which provides health intelligence in moments of care to improve patient outcomes, today announced the hiring of its first Chief Engineerin...

Seth Darmstadter Joins Outcome Health as General Counsel

CHICAGO, Oct. 3, 2017 /PRNewswire/ -- Outcome Health, which provides health intelligence in moments of care to improve patient outcomes, today announced the appointment of Seth Darmstadter as its...

Outcome Health Earns Point-of-Care Industry's First Independent Certification for Audience Qualification and Impression Measurement from BPA Worldwide

SHELTON, Conn. and CHICAGO, Sept. 27, 2017 /PRNewswire/ -- Outcome Health announced it has received independent certification of its health intelligence platform in accordance with the BPA W...

Empagliflozin Lowers CKD Incidence in T2D Patients

(MedPage Today) -- Post-hoc analysis of the EMPA-REG OUTCOME trial

VBL Therapeutics Announces Positive Outcome in the Third and Final DSMC Review of Phase 3 GLOBE Trial Investigating VB-111 in Recurrent GBM

Top-line data expected in Q1 2018 TEL AVIV, Israel, Oct. 02, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), today announced that the independent Data Safety Monitoring Committee (DSMC...

Mayor Emanuel Marks Chicago's Emergence As A National Health-Tech Leader At Announcement Of New Outcome Health Tower

CHICAGO, Sept. 26, 2017 /PRNewswire/ -- Mayor Rahm Emanuel today joined Outcome Health to announce the Chicago-based company is planning to add 2,000 new employees, helping drive the city's emergence ...

Madrigal Pharmaceuticals Announces Positive Outcome from Pre-Planned DSMB Safety Review and Completion of Enrollment of Phase 2 Study of MGL-3196 in Patients with Heterozygous Familial Hypercholesterolemia

-- Second DSMB review includes data from both Phase 2 studies in NASH and HeFH -- -- Top-line results from NASH expected late 2017 and HeFH early 2018 -- CONSHOHOCKEN, Pa., Sept. 19, 2017 (GLO...

Jardiance cuts risk of cardiovascular death in type 2 diabetics and established CV disease

New analyses of the landmark EMPA-REG OUTCOME trial showed that Jardiance (empagliflozin) reduced the…

PubMed Articles [623 Associated PubMed Articles listed on BioPortfolio]

Cardiorenal protection with SGLT2 inhibitors (gliflozins) : from EMPA-REG OUTCOME to CANVAS.

The cardiovascular (CV) and renal protection reported with empagliflozin in EMPA-REG OUTCOME is now confirmed with canagliflozin in CANVAS in patients with type 2 diabetes and high cardiovascular risk...

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial.

Empagliflozin reduced the risk of cardiovascular (CV) death and heart failure (HF) hospitalizations in patients with type 2 diabetes (T2D) and established CV disease (CVD) in the EMPA-REG OUTCOME® tr...

Erratum.

Corrigendum.

Sex and aging.

Clinical Trials [175 Associated Clinical Trials listed on BioPortfolio]

M-learning to Improve Professional Competencies in Health Sciences

The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia

The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

Companies [1031 Associated Companies listed on BioPortfolio]

Outcomes Pharmaceutical Health Care

Outcome is the leading provider of patient registries, studies, quality improvement programs, and integrated technologies for evaluating real-world outcomes. Outcome provides serv...

Outcome Sciences, Inc.

Outcome is the leading provider of patient registries, studies, quality improvement programs, and integrated technologies for evaluating real-world outcomes. Outcome provides serv...

Outcome

Outcome is the leading provider of strategies and solutions designed to meet the unique needs of the post-approval market. The Company focuses on program strategy and the practical deployment of regis...

DVS Sciences, Inc.

DVS Sciences is a life sciences technology company that has developed and manufactures a novel technology for highly multiplexed analysis of single cells. DVS Sciences has an R&D ...

Origin Sciences Limited

Origin Sciences is a medical technology company developing innovative devices and tests to aid the detection and diagnosis of gastrointestinal diseases. Origin Sciences is based i...

More Information about "Outcome Sciences, Inc." on BioPortfolio

We have published hundreds of Outcome Sciences, Inc. news stories on BioPortfolio along with dozens of Outcome Sciences, Inc. Clinical Trials and PubMed Articles about Outcome Sciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Outcome Sciences, Inc. Companies in our database. You can also find out about relevant Outcome Sciences, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record